StageZero Life Sciences Statistics
Total Valuation
SZLSF has a market cap or net worth of 3.64 million. The enterprise value is 4.97 million.
| Market Cap | 3.64M |
| Enterprise Value | 4.97M |
Important Dates
The next estimated earnings date is Friday, August 15, 2025.
| Earnings Date | Aug 15, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 123.55M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.26 |
| PB Ratio | -0.40 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.40 |
| EV / Sales | 1.73 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.04
| Current Ratio | 0.04 |
| Quick Ratio | 0.01 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -11.66 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -63.79% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 58.61% |
| Revenue Per Employee | 72,056 |
| Profits Per Employee | -313,334 |
| Employee Count | 40 |
| Asset Turnover | 0.65 |
| Inventory Turnover | 21.86 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +100.00% in the last 52 weeks. The beta is 0.31, so SZLSF's price volatility has been lower than the market average.
| Beta (5Y) | 0.31 |
| 52-Week Price Change | +100.00% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.03 |
| Relative Strength Index (RSI) | 66.32 |
| Average Volume (20 Days) | 1,289 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SZLSF had revenue of 2.88 million and -12.53 million in losses. Loss per share was -0.12.
| Revenue | 2.88M |
| Gross Profit | 29,994 |
| Operating Income | -4.55M |
| Pretax Income | -12.53M |
| Net Income | -12.53M |
| EBITDA | -4.46M |
| EBIT | -4.55M |
| Loss Per Share | -0.12 |
Balance Sheet
The company has 24,092 in cash and 1.36 million in debt, giving a net cash position of -1.33 million.
| Cash & Cash Equivalents | 24,092 |
| Total Debt | 1.36M |
| Net Cash | -1.33M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -9.07M |
| Book Value Per Share | -0.07 |
| Working Capital | -7.98M |
Cash Flow
| Operating Cash Flow | -809,155 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 1.04% |
| Operating Margin | -157.83% |
| Pretax Margin | -434.85% |
| Profit Margin | n/a |
| EBITDA Margin | -154.88% |
| EBIT Margin | -157.83% |
| FCF Margin | n/a |
Dividends & Yields
SZLSF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -32.99% |
| Shareholder Yield | n/a |
| Earnings Yield | -344.52% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 18, 2020. It was a reverse split with a ratio of 0.125.
| Last Split Date | Sep 18, 2020 |
| Split Type | Reverse |
| Split Ratio | 0.125 |
Scores
SZLSF has an Altman Z-Score of -389.39 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -389.39 |
| Piotroski F-Score | 3 |